|
ELMOD2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.795300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.678000E-02 |
| Normal-vs-Stage2 |
3.276100E-02 |
| Normal-vs-Stage3 |
4.954600E-01 |
| Normal-vs-Stage4 |
5.828800E-01 |
| Stage1-vs-Stage2 |
3.240000E-01 |
| Stage1-vs-Stage3 |
7.158000E-01 |
| Stage1-vs-Stage4 |
2.654400E-01 |
| Stage2-vs-Stage3 |
2.510600E-01 |
| Stage2-vs-Stage4 |
6.910500E-02 |
| Stage3-vs-Stage4 |
4.084600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.523000E-03 |
| Normal-vs-AfricanAmerican |
2.247600E-01 |
| Normal-vs-Asian |
7.803200E-01 |
| Caucasian-vs-AfricanAmerican |
3.590400E-01 |
| Caucasian-vs-Asian |
3.705800E-01 |
| AfricanAmerican-vs-Asian |
4.864200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.262100E-02 |
| Normal-vs-Female |
3.123900E-03 |
| Male-vs-Female |
8.148300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.710800E-01 |
| Normal-vs-Extreme_Weight |
2.865200E-01 |
| Normal-vs-Obese |
6.201400E-03 |
| Normal-vs-Extreme_Obese |
4.274400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.652400E-01 |
| Normal_Weight-vs-Obese |
7.618500E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.279800E-01 |
| Extreme_Weight-vs-Obese |
1.505770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.418200E-01 |
| Obese-vs-Extreme_Obese |
5.662000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.465000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.117730E-03 |
| Normal-vs-Age(61-80Yrs) |
1.095950E-01 |
| Normal-vs-Age(81-100Yrs) |
6.658800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.285000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.869400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.041000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.093790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.991500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.600400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.062600E-03 |
| Normal-VS-Type2 PRCC |
2.813800E-01 |
| Normal-VS-KIRP CIMP |
9.976600E-01 |
| Normal-VS-Unclassified PRCC |
4.000300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.313600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.304000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.115600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.515400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.014200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.652000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.201000E-01 |
| Normal-vs-N1 |
7.779800E-01 |
| Normal-vs-N2 |
2.788600E-01 |
| N0-vs-N1 |
8.195200E-01 |
| N0-vs-N2 |
4.550600E-01 |
| N1-vs-N2 |
5.892600E-01 |
|
|
